Current evidence on the management of hepatitis B in pregnancy

doi:10.4254/wjh.v10.i9.585

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 9

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6106)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series.

Item

Count

PDF

558

WORD

261

HTML

3252

Figures (1-3)

148

Sum=4219

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

856

Download

1031

Sum=1887

Sep 27, 2018 (publication date) through May 8, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Hepatol. Sep 27, 2018; 10(9): 585-594
Published online Sep 27, 2018. doi: 10.4254/wjh.v10.i9.585

Open in New Tab Full Size Figure Download Figure

Figure 1 Hepatitis B in pregnancy: The two side of the problem.

Open in New Tab Full Size Figure Download Figure

Figure 2 Treatment of acute and chronic hepatitis B in pregnancy. The column marked by the red circle refers to interventions that are not allowed. The column marked by the yellow circle refers to interventions that are backed up by low-quality or conflicting evidence. The column marked by the green circle refers to the best practice according to current evidence. IFN: Interferon; NA: Nucleos(t)ide analogue; LAM: Lamivudine; TDF: Tenofovir disoproxil fumarate.

Open in New Tab Full Size Figure Download Figure

Figure 3 Prevention of hepatitis B virus vertical transmission. The column marked by the red circle refers to interventions that are not allowed. The column marked by the yellow circle refers to interventions that are backed up by low-quality or conflicting evidence. The column marked by the green circle refers to the best practice according to current evidence. TDF: Tenofovir disoproxil fumarate; IU: International units; C-section: Caesarean section; HBIG: Hepatitis B immunoglobulin.

Citation: Maraolo AE, Gentile I, Buonomo AR, Pinchera B, Borgia G. Current evidence on the management of hepatitis B in pregnancy. World J Hepatol 2018; 10(9): 585-594
URL: https://www.wjgnet.com/1948-5182/full/v10/i9/585.htm
DOI: https://dx.doi.org/10.4254/wjh.v10.i9.585